Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03926936
What this trial is testing

FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

Who this might be right for
Endometrial Stromal SarcomaAdenosarcoma of UterusLeiomyosarcoma Uterus+3 more
Frederic Amant 17
Not applicableNot Yet RecruitingNCT05633199
What this trial is testing

Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Cytoreductive Surgery
Women's Hospital School Of Medicine Zhejiang University 140
Not applicableNot Yet RecruitingNCT06102707
What this trial is testing

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer Recurrent
Qilu Hospital of Shandong University 50
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Not applicableStudy completedNCT03505307
What this trial is testing

Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)

Who this might be right for
Ovarian Cancer
AstraZeneca 846
Testing effectiveness (Phase 2)Study completedNCT00979992
What this trial is testing

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT00004909
What this trial is testing

Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer

Who this might be right for
Ovarian CancerMalignant Tumor of PeritoneumQuality of Life
Northwestern University 40
Early research (Phase 1)Study completedNCT00004032
What this trial is testing

Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

Who this might be right for
Recurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT04556071
What this trial is testing

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsEndocrine Gland Neoplasms+21 more
Xiaoxiang Chen 32
Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Not applicableStudy completedNCT03270995
What this trial is testing

Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+1 more
McGill University 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467670
What this trial is testing

Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Alexander B Olawaiye, MD 16
Not applicableStudy completedNCT02714621
What this trial is testing

MR-HIFU for Recurrent Gynaecological Cancer

Who this might be right for
Cervical CancerEndometrial CancerUterine Cancer+3 more
Institute of Cancer Research, United Kingdom 31
Early research (Phase 1)Study completedNCT00346385
What this trial is testing

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Ovarian CancerMerkel Cell CarcinomaSCLC
ImmunoGen, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Testing effectiveness (Phase 2)Study completedNCT03759587
What this trial is testing

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 19
Testing effectiveness (Phase 2)Ended earlyNCT00002478
What this trial is testing

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Who this might be right for
Cervical CancerOvarian Cancer
Gynecologic Oncology Group
Not applicableNot Yet RecruitingNCT05921149
What this trial is testing

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapeutic Toxicity
Endeavor Health 170
Early research (Phase 1)Ended earlyNCT02476955
What this trial is testing

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Who this might be right for
Solid TumorsOvarian CancerEndometrial Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 29
Next Page